| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 245 | 4.788 | 11.414 | 12.173 | 9.401 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 245 | 4.788 | 11.415 | 12.174 | 9.402 | 0 | 0 | 1.314 | 0 | 0 |
| Total Expenses - EUR | 115 | 1.068 | 3.468 | 5.584 | 3.416 | 0 | 0 | 1.535 | 0 | 0 |
| Gross Profit/Loss - EUR | 130 | 3.720 | 7.947 | 6.591 | 5.986 | 0 | 0 | -221 | 0 | 0 |
| Net Profit/Loss - EUR | 123 | 3.576 | 7.604 | 6.225 | 5.704 | 0 | 0 | -261 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tudorix Med 2014 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 204 | 151 | 3.519 | 2.424 | 1.365 | 1.339 | 1.310 | 0 | 0 | 0 |
| Current Assets | 2 | 3.472 | 7.633 | 10.039 | 4.389 | 4.306 | 4.211 | 49 | 49 | 48 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2 | 3.472 | 7.633 | 10.039 | 4.389 | 4.306 | 4.211 | 49 | 49 | 48 |
| Shareholders Funds | -68 | 3.509 | 11.054 | 12.349 | 5.754 | 5.645 | 5.520 | 49 | 49 | 48 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 273 | 114 | 99 | 114 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7021 - 7021" | |||||||||
| CAEN Financial Year |
7021
|
|||||||||
Comments - Tudorix Med 2014 Srl